BRPI0919194A2 - preparação sólida para administração oral - Google Patents

preparação sólida para administração oral

Info

Publication number
BRPI0919194A2
BRPI0919194A2 BRPI0919194A BRPI0919194A BRPI0919194A2 BR PI0919194 A2 BRPI0919194 A2 BR PI0919194A2 BR PI0919194 A BRPI0919194 A BR PI0919194A BR PI0919194 A BRPI0919194 A BR PI0919194A BR PI0919194 A2 BRPI0919194 A2 BR PI0919194A2
Authority
BR
Brazil
Prior art keywords
oral administration
solid preparation
preparation
solid
oral
Prior art date
Application number
BRPI0919194A
Other languages
English (en)
Inventor
Azusa Narita
Ken Matsubara
Takeshi Matsushita
Yusuke Mochizuki
Original Assignee
Daiichi Sankyo Healthcare Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41797176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0919194(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Healthcare Co filed Critical Daiichi Sankyo Healthcare Co
Publication of BRPI0919194A2 publication Critical patent/BRPI0919194A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
BRPI0919194A 2008-09-05 2009-09-03 preparação sólida para administração oral BRPI0919194A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008227971 2008-09-05
PCT/JP2009/065390 WO2010027010A1 (ja) 2008-09-05 2009-09-03 有効成分が境界を有してなる医薬固形製剤

Publications (1)

Publication Number Publication Date
BRPI0919194A2 true BRPI0919194A2 (pt) 2015-12-15

Family

ID=41797176

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919194A BRPI0919194A2 (pt) 2008-09-05 2009-09-03 preparação sólida para administração oral

Country Status (9)

Country Link
EP (1) EP2335698B8 (pt)
JP (1) JP5579066B2 (pt)
KR (1) KR101640958B1 (pt)
CN (1) CN102137664B (pt)
BR (1) BRPI0919194A2 (pt)
HK (1) HK1152652A1 (pt)
MX (1) MX2011002400A (pt)
TW (1) TWI436763B (pt)
WO (1) WO2010027010A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335697B1 (en) * 2008-09-12 2014-03-12 Daiichi Sankyo Healthcare Co., Ltd. Stable pharmaceutical formulation with limited discoloration
EP2695605B1 (en) 2012-08-07 2017-05-03 Parapharm Development Ltd. Tranexamic acid composition
CN103054861A (zh) * 2012-12-29 2013-04-24 北京阜康仁生物制药科技有限公司 一种含氨甲环酸的复方固体制剂
CN109793757B (zh) * 2019-03-28 2021-06-22 北京刷新活力健康科技有限公司 一种抑制皮肤瘢痕生长的组合物及其制备方法和应用
JP2021001126A (ja) * 2019-06-20 2021-01-07 小林製薬株式会社 ケラチノサイト内メラノソーム分解促進剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102073A (ja) * 1987-10-15 1989-04-19 Takeda Chem Ind Ltd 安定なアスコルビン酸粉末およびその製造法
JPH04243825A (ja) 1991-01-25 1992-08-31 Ss Pharmaceut Co Ltd 色素沈着症治療剤
TW271406B (pt) * 1992-04-17 1996-03-01 Takeda Pharm Industry Co Ltd
JP2001294524A (ja) * 2000-04-12 2001-10-23 Taisho Pharmaceut Co Ltd アセトアミノフェン配合内服固形製剤
JP4786127B2 (ja) * 2002-07-12 2011-10-05 任康 高田 色素沈着改善治療薬
EP1586315B1 (en) * 2002-12-27 2010-04-14 Daiichi Sankyo Healthcare Co., Ltd. Skin lightening composition
JP2004217655A (ja) 2002-12-27 2004-08-05 Dai Ichi Seiyaku Co Ltd 美白用組成物
WO2005019286A1 (ja) * 2003-08-20 2005-03-03 Shionogi & Co., Ltd. 新規コーティング組成物
JP2005314403A (ja) * 2004-03-31 2005-11-10 Dai Ichi Seiyaku Co Ltd 新規美白用組成物
JPWO2006003965A1 (ja) * 2004-06-30 2008-04-17 第一三共ヘルスケア株式会社 美白組成物
JP4768404B2 (ja) * 2005-11-08 2011-09-07 株式会社 資生堂 イオントフォレーシスによる美容方法
JP2008201711A (ja) * 2007-02-20 2008-09-04 Ss Pharmaceut Co Ltd システイン臭が低減された固形製剤

Also Published As

Publication number Publication date
TW201016213A (en) 2010-05-01
EP2335698B8 (en) 2014-06-25
KR20110057145A (ko) 2011-05-31
TWI436763B (zh) 2014-05-11
EP2335698A4 (en) 2011-10-12
KR101640958B1 (ko) 2016-07-19
WO2010027010A1 (ja) 2010-03-11
JP5579066B2 (ja) 2014-08-27
CN102137664A (zh) 2011-07-27
EP2335698A1 (en) 2011-06-22
HK1152652A1 (en) 2012-03-09
MX2011002400A (es) 2011-04-07
JPWO2010027010A1 (ja) 2012-02-02
EP2335698B1 (en) 2014-03-26
CN102137664B (zh) 2014-08-06

Similar Documents

Publication Publication Date Title
DK2328601T3 (da) Linaclotid-holdige formuleringer til oral indgivelse
BRPI0914713A2 (pt) composição para cuidado oral
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
BRPI0807453A2 (pt) Preparação sólida
BRPI0820381A2 (pt) Formulações farmacêuticas
BRPI0822722A2 (pt) Implemento para cuidado oral.
BRPI0906802A2 (pt) Implemento para cuidado oral.
DK2140867T4 (da) Farmaceutisk sammensætning
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0918971A2 (pt) tienopirimidinas para composições farmacêuticas
BRPI0818680A2 (pt) composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica
BRPI1008598A2 (pt) composição farmacêutica para inalação
BRPI1007484A2 (pt) composição farmacêutica para administração oral
BRPI0719394A2 (pt) Preparação medicinal sólida
BR112013016207A2 (pt) composições para cuidados orais
DK2120884T3 (da) Farmaceutisk sammensætning
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0921654A2 (pt) formulação farmacêutica
DK2194959T3 (da) Skummedygtig mundplejetilberedning
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0918539A2 (pt) preparação farmacêutica sólida para administração oral
BRPI0922653A2 (pt) preparação farmacêutica
BRPI0812964A2 (pt) Forma de dosagem farmacêutica oral sólida
BRPI0912171A2 (pt) composição farmacêutica
BRPI0812000A2 (pt) Métodos e composições para administração de oxibutinina

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.